Non-erosive Reflux Disease Clinical Trial
Official title:
Predictive Factors of Response to Proton Pump Inhibitor Treatment in Patients With Gastroesophageal Reflux Disease Symptoms
Proton pump inhibitor (PPI) is widely used in patients with gastroesophageal reflux disease (GERD), however, some patients fail to respond to PPI therapy. Recent reporters suggest that depressive disorders, anxiety, sleep dysfunction were related with the symptomatic responses to a PPI treatments. Nevertheless, the predictive factors of response to PPI treatment still remain controversial. Therefore, the aims of this study were to investigate the efficacy of PPI therapy, and to evaluate the predictors of the PPI response in patients with symptomatic GERD by using the questionnaire which consisted of GERD symptoms, GERD impact scale (GIS), Epworth sleepiness scale (ESS), Pittsburgh sleep quality index (PSQI), Hospital anxiety and depression scale (HADS), and WHO quality of life scale abbreviated version (WHOQOL-BREF).
n/a
Observational Model: Case Control, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05587322 -
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
|
Phase 3 | |
| Completed |
NCT02556021 -
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
|
Phase 3 | |
| Completed |
NCT03444883 -
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD
|
Phase 3 | |
| Completed |
NCT03591653 -
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks
|
Phase 3 | |
| Completed |
NCT00562094 -
Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
|
N/A | |
| Completed |
NCT00259077 -
Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
|
Phase 3 | |
| Enrolling by invitation |
NCT02149914 -
The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
|
N/A | |
| Terminated |
NCT00449813 -
The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)
|
Phase 4 | |
| Completed |
NCT02081404 -
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
|
N/A | |
| Recruiting |
NCT04255693 -
Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence
|
N/A | |
| Recruiting |
NCT04252144 -
Study of Dietary Patterns and Food Diversity in Russian GERD Patients
|
N/A | |
| Recruiting |
NCT02892357 -
Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT01750437 -
Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
|
Phase 2 | |
| Completed |
NCT01560910 -
Detection of Minimal Change Esophagitis by I-scan
|
N/A | |
| Completed |
NCT00830115 -
Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
|
N/A | |
| Completed |
NCT00259051 -
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
|
Phase 3 | |
| Not yet recruiting |
NCT04759378 -
Comorbid Esophageal Disorders in IBS Patients
|
N/A | |
| Recruiting |
NCT05369884 -
Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D
|
Early Phase 1 | |
| Recruiting |
NCT06121830 -
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)
|
Phase 3 | |
| Terminated |
NCT02788591 -
Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection
|
N/A |